Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 15, 2026
April 17, 2026
40eaf0fa-a852-4796-a330-c72e8bce14e2
Related Documents
A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry
Guidance DocumentApril 12, 2023Center for Drug Evaluation and Research
Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
Charging for Investigational Drugs Under an IND: Questions and Answers
Guidance DocumentFebruary 14, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.